Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Go back to Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
(NASDAQ: VVOS) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High
Open $0.47    52 Week Low
Day High $0.47    P/E N/A 
Day Low $0.47    EPS
Volume 52